Re: the Legs For Life screening for peripheral vascular disease: compliance with physician recommendations in moderate- and high-risk assessed patients.
Explore the source record for details and available documents.
Humans↗
Biomedical subjects
F Castaneda
Publications and source records attributed to F Castaneda.
[Comparison of liver resection with sequential transarterial chemoembolization in stage pT3 or pT4 hepatocellular carcinoma].
Between January 1990 and January 1996, 39 consecutive patients with histologically improved pT3 or pT4 HCC tumors underwent curative resection (n = 19) or sequential transarterial chemoembolization (n = 20) with a median time interval of 7 weeks up to six times with an emulsion of Lipiodol, Epirubicin and Cisplatin. The 30-day mortality rate for all sessions of TA was 3.8% vs. 21.8% in the resection group (p < 0.05); the cumulative survival rate for the embolization group at 6, 12, 18 and 24 months was 72.3%, 50.1%, 41.2%, 35.4% vs. 42.1%, 31.6%, 31.6% and 14.2% following resection, which cannot be considered statistically significant. Patients with T3 and T4 HCC, treated with sequential embolization or resection, seem to have a comparable survival time.
Carcinoma, Hepatocellular↗
Complications of laparoscopic cholecystectomy and their interventional radiologic management.
Cholelithiasis and cholecystitis are encountered throughout the world and are responsible for the majority of cholecystectomies performed. Treatment has traditionally consisted of open cholecystectomy, but laparoscopic cholecystectomy is currently a popular alternative. Laparoscopic cholecystectomy offers several benefits over the open procedure, but it also has its own set of complications. Complications include those of laparoscopy (abdominal wall bleeding, omental bleeding, abdominal vessel injury, retroperitoneal vessel injury, gastrointestinal perforation, bladder perforation, solid visceral injury, and infection) and those of cholecystectomy (gallbladder fossa bleeding, bile duct injury, bile leakage, and infection). The literature suggests that the total complication rate for the laparoscopic procedure compares favorably with that of the open procedure, but this may apply only to surgeons who have accomplished numerous laparoscopic procedures and not to those who have just completed a training course and are performing their first few procedures. With the growing success of the laparoscopic procedure, it is essential that the radiologist be knowledgeable about the radiographic manifestations and interventional radiologic management of potential complications, since the radiologist can significantly affect patient care.
Abdomen↗
Two urokinase dose regimens in native arterial and graft occlusions: initial results of a prospective, randomized clinical trial.
The effects of two urokinase (UK) dose regimens on lysis time, lytic success, primary clinical success, and frequency of complications of peripheral thrombolysis were compared. Seventy-two intraarterial UK infusions were performed by means of standard catheter-directed infusion techniques in 63 patients with symptomatic peripheral arterial or bypass graft occlusions. Patients were prospectively randomized to high-dose (250,000 U/h for 4 hours and then 125,000 U/h) or low-dose (50,000 U/h) regimens. The mean time to complete lysis was 20.8, 26.0, 16.5, and 18.2 hours for the high-dose artery, low-dose artery, high-dose graft, and low-dose graft groups, respectively (P was not significant). Respective mean infusion durations were 27.1, 35.4, 22.2, and 25.3 hours. Clinical success was achieved in 65%-85% of cases. The frequency of complications was equivalent between groups, except for a higher frequency of minor bleeding complications in the high-dose group. The two urokinase dose regimens studied were equally effective in enabling peripheral thrombolysis.
Angiography↗
Prostatic urethroplasty with balloon catheter as a nonsurgical alternative for benign prostatic hyperplasia.
Prostatic urethroplasty with a balloon catheter is an easy procedure to perform, but certain guidelines must be followed to avoid complications. This procedure will reduce the overall treatment cost of benign prostatic hyperplasia significantly. Preliminary results range from 70% to 85% symptomatic improvement or resolution of the prostatism symptoms. Its recurrence rate is still not known, but a small one is expected. Nevertheless, because of the noninvasiveness, low cost, and simplicity of the procedure, it potentially could be repeated, if necessary. This procedure is one that when it is done in combination with another specialist, in this case a urologist, the patient will benefit by the use of the expertise of both the urologist's knowledge of the disease of the urinary system and the interventional radiologist's skills with catheters and guide wires.
Catheterization↗
Perineal abscess after prostatic urethroplasty with balloon catheter: report of a case.
A 72-year-old patient underwent uneventful prostatic urethroplasty by means of a balloon catheter. The immediate follow-up retrograde urethrogram failed to demonstrate any areas of extravasation and showed a significant increase in prostatic urethral caliber. Three weeks after the patient was discharged, computed tomography demonstrated a large perineal abscess that was attributed to either the prostatic urethroplasty or subsequent Foley catheter manipulations. The abscess was drained percutaneously, and the patient recovered uneventfully. It was concluded that the abscess was a possible isolated complication and that the procedure is warranted in an adequate clinical setting.
Abscess↗
New guide wire for high-flow infusion.
A new open-ended guide wire with a large internal diameter was compared with two other open-ended guide-wire and catheter infusion systems. Simple experiments were performed to compare flow rates and ability to track. The larger internal diameter of the new wire allowed higher flow rates and accepted an 0.025-inch (0.64-mm) guide wire. The flexibility of the new infusion wire was shown to be equivalent to that of the catheter system. The authors conclude that the new wire has advantages in terms of flow rates and ability to track, compared with presently available infusion systems.
Catheterization↗
Percutaneous enterostomy with the Cope suture anchor.
Eighty-two percutaneous enterostomies were performed at three institutions with the Cope suture anchor for stomach or jejunal wall stabilization during alimentation tube placement. The anchors were successfully placed into the stomach or jejunum in 81 cases. Early in the series, two anchors were misplaced, with no sequelae. There were no other complications at the time of placement. In all successful cases, excellent immobilization of the viscus was achieved. Tract dilation and tube placement were easily performed, and there were no guidewire or tube dislodgments.
Adult↗
Percutaneous atherectomy as an alternative treatment for postangioplasty obstructive intimal flaps.
Intimal flaps are commonly seen angiographically after percutaneous balloon angioplasty. Nonobstructive flaps are normally of little clinical significance, but flaps that obstruct blood flow may lead to partial or complete thrombosis. The Simpson atherectomy catheter was used to treat obstructive intimal flaps after angioplasty in four patients. Lumen patency was reestablished in all four cases. The clinical results were excellent, with rest pain and claudication resolved in all four patients and distal pulses reestablished in one. These findings suggest that the Simpson atherectomy catheter can be used to remove large obstructive flaps complicating angioplasty.
Aged↗
Thrombosed polytetrafluoroethylene hemodialysis fistulas: salvage with combined thrombectomy and angioplasty.
Combined thrombectomy and angioplasty was performed for 19 thrombosed polytetrafluoroethylene grafts. Patency for more than 1 week was achieved in 16 of the 19 grafts (84%). The average duration of graft function after angioplasty in all 19 grafts was 7.1 months (range, 0-32.3 months). Eleven of the 19 grafts (58%) were functioning 5 months after the procedure; seven are still functioning. Combined thrombectomy and angioplasty offers a viable alternative to thrombolytic therapy or complete surgical revision.
Adult↗
Double-lumen needle for percutaneous ureteral pressure-flow studies.
Ureteral perfusion studies in patients without preexisting renal access currently must be intermittently interrupted for intrarenal pressure measurement. A double-lumen needle has been successfully placed in four patients (two with native and two with transplanted kidneys). This permits simultaneous perfusion and intrarenal pressure monitoring yet maintains the safety and ease of use of a single skinny needle.
Humans↗
A new technique for introduction of large instruments into the vascular system.
A new introducer system for large devices is described, which is easily manufactured from commonly available materials in a hospital environment.
Blood Vessels↗
Alternative treatment of prostatic urethral obstruction secondary to benign prostatic hypertrophy. Non-surgical balloon catheter prostatic dilatation.
Benign prostatic hypertrophy (BPH) produces symptoms that currently can only be treated surgically either by open or endoscopic prostatectomy. We have undertaken animal (1) and human studies to determine if invasive radiologic techniques utilizing balloon catheters could be applied to the treatment of this common ailment. We report a series of twelve patients treated by retrograde transurethral balloon catheter prostatic dilatation. The procedure is performed using topical anesthesia with a specially designed balloon catheter (Medi-Tech, Inc.). The procedure is done on an outpatient basis and is completed within approximately 15 minutes. Relatively long-term results have resulted in persistent relief of symptoms. No complications have been encountered. We anticipate that balloon dilatation of the prostatic urethra will have a major impact on the treatment of BPH based on the promising preliminary results. Transurethral resection of the prostate (TURP) is associated with moderate morbidity and significant cost which can be reduced by the proposed procedure.
Catheterization↗
Prostatic urethra: experimental dilation in dogs.
An animal study was undertaken to develop a balloon dilation technique that could be used in humans to treat the common ailment of benign prostatic hypertrophy. Dogs were used as a model because of the similarities in the prostate between the two species and the ready availability of the canines. A retrograde transurethral approach was used for dilation. Balloon catheters, 8-20 mm in diameter, were used. Significant, long-lasting dilatation of the prostatic urethra was not accomplished until 20-mm balloons (or two 10-mm ones) inflated for 10 minutes were used. The animals were followed for up to 14 months. No deleterious histologic effects of dilation were identified within the urethra or prostate that could lead to stenosis of the prostatic urethra in later stages.
Animals↗
Benign prostatic hypertrophy: retrograde transurethral dilation of the prostatic urethra in humans. Work in progress.
Retrograde transurethral balloon dilation of the prostatic urethra was performed in five human volunteers with benign prostatic hypertrophy. Each patient underwent cystoscopy, uroflow studies, voiding cystourethrography, retrograde urethrography, and magnetic resonance imaging before dilation and at defined intervals afterward. The longest follow-up to date is 8 months. Patients were given topical anesthetics and mild sedatives, and dilation was performed with a 25-mm urethroplasty balloon catheter inflated at 3-6 atm for 10 minutes. All catheter manipulations were done with a guide wire and under fluoroscopic control. Significant resolution of symptoms of prostatism was seen in four patients. The unsatisfactory results in the last patient were believed to be caused by ineffectual dilation of predominantly middle lobe hypertrophy--a condition that is now regarded as a contraindication to dilation. This technique has promise to replace transurethral resection of the prostate as the treatment of choice for this common male ailment.
Aged↗
Urethroplasty with balloon catheter in prostatic hypertrophy.
Explore the source record for details and available documents.
Catheters, Indwelling↗
Nonsurgical placement of arterial endoprostheses: a new technique using nitinol wire.
A new type of endovascular prosthesis has been developed using a unique metal alloy (nitinol) with a heat-sensitive memory. Nitinol wire coil grafts were straightened in ice water and passed into the canine aorta via catheter, where they reformed into their original shapes. Follow-up aortograms demonstrated long-term patency with minimal thrombus formation. Nitinol endovascular coil grafts may eventually be used in the nonsurgical treatment of several forms of vascular disease.
Alloys↗
Detachable stainless-steel spider. A new device for vessel occlusion.
A new device for transcatheter vessel occlusion consists of a stainless-steel spider which can be screwed onto a threaded guide wire. Since the spider can be retrieved after it is extruded from the catheter, accurate placement is possible. The device was tested in the aorta and pulmonary artery of dogs. The spider blocked the movement of steel coils and wool streamers and occluded the vessel. This device is particularly useful for occlusion of large arteriovenous fistulas in the lungs.
Animals↗